In February 2012, the company announced a partnership with Geisinger Health System and the University of California, San Francisco, to develop the DNAnexus technology for application in clinical medicine.
•
In October 2011, DNAnexus announced that it had raised $15 million from Google Ventures, TPG Biotech, First Round Capital, SoftTech VC, K9 Ventures, and Felicis Ventures.